Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Greaves, Ronda / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter


IMPACT FACTOR 2018: 3.638

CiteScore 2018: 2.44

SCImago Journal Rank (SJR) 2018: 1.191
Source Normalized Impact per Paper (SNIP) 2018: 1.205

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 36, Issue 7

Issues

Biological Day-to-Day Variation and Daytime Changes of Testosterone, Follitropin, Lutropin and Oestradiol-17β in Healthy Men

Outi Ahokoski / Arja Virtanen / Risto Huupponen / Harry Scheinin / Eeva Salminen / Veli Kairisto / Kerttu Irjala
Published Online: 2005-06-01 | DOI: https://doi.org/10.1515/CCLM.1998.081

Abstract

Information on biological day-to-day variation is needed for detecting within-subject changes over time. In this study the daytime changes and the biological day-to-day variation of serum testosterone, follitropin, lutropin and oestradiol-17β concentrations were investigated in 31 healthy males.

To analyse daytime changes, blood specimens were taken at 0800 h, 1200 h, 1600 h and 2000 h during one day (n=31) and two days (n=8). The day-to-day variation was analysed from blood specimens collected at 0800 h on days 1 and 2 (n=31) and additionally on days 3, 4, 6 and 9 (n=8). The evaluation of the day-to-day variation was based on calculations of the within-subject (CVA+I) and between-subject (CVG) coefficients of variation. When the within-subject day-to-day variances were not too heterogeneous, they were used for the calculation of 95 % reference change limits.

Serum testosterone and oestradiol-17βconcentrations showed a significant daytime variation; testosterone had higher serum concentrations at 0800 and 1200 h. A peak in the serum concentration of oestradiol-17β occurred at 1200 h with a decrease towards the evening. There were no clear daytime changes in the serum concentrations of follitropin or lutropin.

For different analytes the reference change limits were: serum testosterone ± 32.0 %, serum follitropin ± 24.1 % and serum oestradiol-17β ± 38.3 %. The reference change limit was not calculated for serum lutropin, as a high degree of heterogeneity and individuality was found.

The interpretation of the results of hormone measurements requires recognition of the biological daytime and day-to-day changes of hormones. The reference change limits determine what changes are significant when monitoring the patient.

About the article

Published Online: 2005-06-01

Published in Print: 1998-07-01


Citation Information: Clinical Chemistry and Laboratory Medicine, Volume 36, Issue 7, Pages 485–491, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.1998.081.

Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Peter B Gray, Benjamin C Campbell, Frank W Marlowe, Susan F Lipson, and Peter T Ellison
Psychoneuroendocrinology, 2004, Volume 29, Number 9, Page 1153
[2]
Pål Klepstad, Priscilla Hilton, Jorunn Moen, Stein Kaasa, Petter C Borchgrevink, Kolbjørn Zahlsen, and Ola Dale
BMC Clinical Pharmacology, 2004, Volume 4, Number 1
[3]
Landon W. Trost and John P. Mulhall
The Journal of Sexual Medicine, 2016, Volume 13, Number 7, Page 1029
[4]
H.N. Bui, P.M. Sluss, F.J. Hayes, S. Blincko, D.L. Knol, M.A. Blankenstein, and A.C. Heijboer
Clinica Chimica Acta, 2015, Volume 450, Page 227
[6]
Michael R. Graham, Julien S. Baker, Peter Evans, Andrew Kicman, David Cowan, David Hullin, and Bruce Davies
Growth Hormone & IGF Research, 2007, Volume 17, Number 3, Page 201
[7]
Michael R. Graham, Julien S. Baker, Peter Evans, Andrew Kicman, David Cowan, David Hullin, and Bruce Davies
Growth Hormone & IGF Research, 2007, Volume 17, Number 4, Page 328
[8]
Kevin R. Loughlin
The Journal of Urology, 2004, Volume 172, Number 3, Page 827
[9]
Marita Kailajärvi, Outi Ahokoski, Arja Virtanen, Eeva Salminen, and Kerttu Irjala
Clinical Chemistry and Laboratory Medicine, 2000, Volume 38, Number 5
[10]
Donald J. Brambilla, Amy B. O'Donnell, Alvin M. Matsumoto, and John B. McKinlay
Clinical Endocrinology, 2007, Volume 67, Number 6, Page 853
[11]
Michael R. Graham, Julien S. Baker, Peter Evans, Andrew Kicman, David Cowan, David Hullin, Non Thomas, and Bruce Davies
Hormone Research in Paediatrics, 2008, Volume 69, Number 6, Page 343
[12]
F Sluyter, JN Keijser, DI Boomsma, LJP van Doornen, EJCG van den Oord, and H Snieder
Twin Research, 2000, Volume 3, Number 04, Page 266

Comments (0)

Please log in or register to comment.
Log in